NJ centric issues and concerns regarding COVID-19

During this time communication is critical. NJSHP would like to support the health-system members and residents of New Jersey. 

Please send any suggested content to Stella Williams (swilliams@njha.com) so we can review and share them as appropriate.

ASHP has consolidated information on COVID-19

Click here to view the provided resources

Quick Links

NJBOP

NJDOH

ASHP

CDC

FDA

USP

WHO

General Information

Useful links on COVID-19 resources

John Hopkins University

Current UW Medicine protocols:
UW Medicine 

Wolters Kluwer

Penn Medicine's treatment guidelines

Michigan Medicine treatment guidelines

Drug and Prescription Updates Recent publications on medication management with COVID-19

Drug diversion by the DEA

ACE Inhibitors and ARBs use

Darunavir treatment lacking evidence

USP/Compounding Updates In light of the rapidly evolving COVID-19 pandemic, the demand for garbing and personal protective equipment (PPE) and alcohol-based hand sanitizer is expected to outpace available supply. During this pandemic, USP supports State Boards and other regulators using risk-based enforcement discretion related to the implementation of USP compounding standards and the compounding of alcohol-based sanitizers for consumer use.

The USP Compounding Expert Committee developed the following information resources that may be of assistance during this public health emergency:

- Compounding Alcohol-Based Hand Sanitizer During the COVID-19 Pandemic

- USP Response to Shortages of Garb and PPE for Sterile Compounding During the COVID-19 Pandemic

Any additional questions should be directed to the USP Healthcare Quality and Safety staff at compoundingsl@usp.org